Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × thymoglobulin × 30 days × Clear all

Sponsor

Conditions

beta-Thalassemia 1 Vasculitis, Central Nervous System 1 Thalassemia 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Rasmussen subacute encephalitis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Large Granular Lymphocytic 1 Lambert-Eaton Myasthenic Syndrome 1 Hodgkin Disease 1 Hemoglobinuria, Paroxysmal 1 Congenital amegakaryocytic thrombocytopenia 1 Bone Marrow Failure Disorders 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1 Anemia, Sickle Cell 1 Anemia, Hypochromic 1 Anemia, Diamond-Blackfan 1

Interventions

ibrutinib 4 Rituximab 4 zanubrutinib 3 venetoclax 2 ixazomib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Biopsy 2 talquetamab 1 pirtobrutinib 1 fludarabine 1 brexucabtagene autoleucel 1 Vincristine 1 Valacyclovir 1 Sirolimus 1 Pharmacogenomic Variants 1 Lenalidomide 1 Everolimus 1 Etoposide 1 Doxorubicin 1 Bortezomib 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡